Journal for ImmunoTherapy of Cancer (Nov 2023)
1259 Comparison of blinatumomab and biosimilar CD19xCD3 BiTE responses in PBMC-humanized mice used as a preclinical lymphoma mouse model
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)